Gilead Sciences, Inc.

Gediminas J Brizgys

Chienhung Chou

James G Taylor

Jeromy J Cottell

Nathan E Wright

Zheng-Yu Yang

Sheila M Zipfel

Elbert Chin

Stephen E Ammann

Jennifer R Zhang

Elizabeth M Bacon

Winston C Tse

Scott D Schroeder

Michael Graupe

John O Link

Michael L Mitchell

Eda Y Canales

Roland D Saito

Randall Halcomb

Jiayao Li

Qiaoyin Wu

Rhiannon Thomas-Tran

Hong Yang

Lianhong Xu

Hongtao Liu

Paul A Roethle

Qi Liu

Ryan McFadden

Kerim Babaoglu

Nathan D Shapiro

Yunfeng Eric Hu

Darryl Kato

Bing Shi

Hongyan Guo

Xianghong Wang

Scott Alan Wolckenhauer

William John Watkins

Scott E Lazerwith

Richard Y Huang

Randall W Vivian

Xiaowu Chen

Hang Chu

Julie Farand

Willard Lew

Xiaochun Han

Lars V Heumann

Marilyn Ndukwe

Chao-I Hung

James S Cassidy

Kavoos Kolahdouzan

Suzanne M Szewczyk

Stephen Ammann

Marina Shatskikh

Yingmei Qi

Anna Michelle Wagner

Trevor James Rainey

Vinh Xuan Ngo

Brian Michael O'Keefe

John R Somoza

Amanda Lynn Vandehey

Chien-Hung Chou

Paul Hrvatin

Yafan Lu

Benjamin James Roberts

Daniel G Shore

Chien-hung Chou

Eric Lansdon

Zilin Huang

Dietrich P Steinhuebel

James B C Mack

Tezcan Guney

Ezra Roberts

Randall L Halcomb

Shahrokh Kazerani

Dong Min Mun

Sachin Dhar

Jake Cha

Chloe Y Wong

Ryan Mcfadden

Richard Huang

Kevin Mccormack Allan

Ian James Doxsee

Alex Goldberg

Nathaniel Thomas Kadunce

Chloe Yuyi Wong

The present disclosure provides GLP-1R agonists, and compositions, methods, and kits thereof. Such compounds are generally useful for treating a GLP-1R mediated disease or condition in a human.

GLP-1R modulating compounds

A compound of Formula (I): pharmaceutically acceptable salts thereof, deuterated analogs thereof, compositions thereof, and methods of treating disease using a compound thereof, wherein the variable substituents are disclosed herein.

Pyrrolo[1,2-b]pyridazine derivatives

The present disclosure relates generally to certain compounds, pharmaceutical compositions comprising said compounds, and methods of making and using said compounds and pharmaceutical compositions. The compounds and compositions provided herein may be used for the treatment or prevention of a Retroviridae infection, including an HIV infection.

Therapeutic compounds for HIV virus infection

The present disclosure provides GLP-1R agonists, and compositions, methods, and kits thereof. Such compounds are generally useful for treating a GLP-1R mediated disease or condition.

A compound of Formula (I): pharmaceutically acceptable salts thereof, deuterated analogs thereof, compositions thereof, and methods of treating disease using a compound thereof are disclosed.

Thiadiazole IRAK4 inhibitors

The invention provides compounds having Formula (I): or a pharmaceutically acceptable salt thereof, as well as pharmaceutical compositions comprising the same, processes for their preparation, and methods of treating and preventing HIV infection by their administration.

Therapeutic compounds

Pyrrolo[1,2-b] pyridazine derivatives

Growing community of inventors

San Carlos, CA, United States of America

Gediminas J Brizgys